ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

IONS Ionis Pharmaceuticals Inc

0.00
0.00 (0.00%)
Share Name Share Symbol Market Type
Ionis Pharmaceuticals Inc NASDAQ:IONS NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0 -

Ionis to present at TD Cowen Genetic Medicines & RNA Summit

17/06/2024 9:09pm

PR Newswire (US)


Ionis Pharmaceuticals (NASDAQ:IONS)
Historical Stock Chart


From Jun 2024 to Jul 2024

Click Here for more Ionis Pharmaceuticals Charts.

CARLSBAD, Calif., June 17, 2024 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will participate in a fireside chat at the virtual TD Cowen Genetic Medicines & RNA Summit on Thursday, June 20, 2024.

Ionis logo (PRNewsfoto/Ionis Pharmaceuticals, Inc.)

A live webcast of this presentation can be accessed on the Investors & Media section of the Ionis website at https://ir.ionis.com/events-and-presentations/upcoming-events. A replay will be available on the Ionis website within 48 hours and will be archived for a limited time.

About Ionis Pharmaceuticals
For three decades, Ionis has invented medicines that bring better futures to people with serious diseases. Ionis currently has five marketed medicines and a leading pipeline in neurology, cardiology, and other areas of high patient need. As the pioneer in RNA-targeted medicines, Ionis continues to drive innovation in RNA therapies in addition to advancing new approaches in gene editing. A deep understanding of disease biology and industry-leading technology propels our work, coupled with a passion and urgency to deliver life-changing advances for patients.

To learn more about Ionis, visit Ionis.com and follow us on X (Twitter) and LinkedIn.

Ionis Pharmaceuticals Investor Contact:
D. Wade Walke, Ph.D. – ir@ionis.com – 760-603-2331

Ionis Pharmaceuticals Media Contact:
Hayley Soffer – media@ionis.com – 760-603-4679

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/ionis-to-present-at-td-cowen-genetic-medicines--rna-summit-302174669.html

SOURCE Ionis Pharmaceuticals, Inc.

Copyright 2024 PR Newswire

1 Year Ionis Pharmaceuticals Chart

1 Year Ionis Pharmaceuticals Chart

1 Month Ionis Pharmaceuticals Chart

1 Month Ionis Pharmaceuticals Chart

Your Recent History

Delayed Upgrade Clock